LXEO — Lexeo Therapeutics, Inc. | XLV Holdings | StockAdder

(LXEO)

Lexeo Therapeutics, Inc.

Live chart and latest LXEO stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

LXEO News

Suvretta, Averill disclose multi-million share holdings in Lexeo Therapeutics (NASDAQ: LXEO)

Apr 13, 2026 ChartMill

LXEO News | LEXEO THERAPEUTICS INC (NASDAQ:LXEO)

Apr 10, 2026 Sahm

Insiders In Lexeo Therapeutics Left Out From 14% Price Rise After Disposing Stock

Apr 9, 2026 Yahoo Finance

Wall Street Rallies Behind Lexeo Therapeutics (LXEO)’s Gene Therapy Pipeline

Dec 27, 2025 Quiver Quantitative

LEXEO THERAPEUTICS Q4 2025 Earnings Preview: Recent $LXEO Insider Trading, Hedge Fund Activity, and More

Mar 13, 2026 TradingView — Track All Markets

LXEO Stock Price and Chart — NASDAQ:LXEO

Nov 25, 2025 GlobeNewswire

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Mar 30, 2026 The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), Bicara Therapeutics Inc. (BCAX) and Compass Therapeutics (CMPX)

Apr 1, 2026 Investing.com

Lexeo Therapeutics stock falls after PKP2 gene therapy data

Jan 12, 2026 Stock Titan

Lexeo says cash lasts into 2028 as pivotal gene therapy trial nears

Mar 30, 2026 Yahoo Finance

Owning 44% shares,institutional owners seem interested in Lexeo Therapeutics, Inc. (NASDAQ:LXEO),

Sep 24, 2025 simplywall.st

Institutional investors have a lot riding on Lexeo Therapeutics, Inc. (NASDAQ:LXEO) with 56% ownership

Jan 10, 2026 The Globe and Mail

Oppenheimer Reaffirms Their Buy Rating on Lexeo Therapeutics, Inc. (LXEO)

Apr 1, 2026 Investing.com

Lexeo Therapeutics stock falls 23% despite Cantor maintaining Overweight rating

Jan 13, 2026 Stock Titan

[144] Lexeo Therapeutics, Inc. SEC Filing